RECK gene expression in hepatocellular carcinoma: correlation with invasion-related clinicopathological factors and its clinical significance. Reverse-inducing--cysteine-rich protein with Kazal motifs

scientific article

RECK gene expression in hepatocellular carcinoma: correlation with invasion-related clinicopathological factors and its clinical significance. Reverse-inducing--cysteine-rich protein with Kazal motifs is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1053/JHEP.2001.21048
P698PubMed publication ID11124835

P2093author name stringTakahashi C
Mori A
Noda M
Isobe N
Murata T
Arii S
Imamura M
Furumoto K
Nakao T
Furuyama H
Gorrin Rivas MJ
P433issue1
P407language of work or nameEnglishQ1860
P921main subjecthepatocellular carcinomaQ1148337
P304page(s)189-195
P577publication date2001-01-01
P1433published inHepatologyQ15724398
P1476titleRECK gene expression in hepatocellular carcinoma: correlation with invasion-related clinicopathological factors and its clinical significance. Reverse-inducing--cysteine-rich protein with Kazal motifs
P478volume33

Reverse relations

cites work (P2860)
Q38739352Anacardic acid inhibits gelatinases through the regulation of Spry2, MMP-14, EMMPRIN and RECK.
Q35440600Association between polymorphisms in tumor suppressor genes and oncogenes and risk of hepatocellular carcinoma: a case-control study in an HCC epidemic area within the Han Chinese population
Q28288148Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade
Q46103336Decreased RECK and Increased EMMPRIN expression in urothelial carcinoma of the bladder are associated with tumor aggressiveness
Q34574350Developmental biology: vasculogenesis is a wreck without RECK.
Q43049939Differential expression of degradome components in cutaneous squamous cell carcinomas
Q39631853Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases.
Q34201053Effect of RECK gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathologic features
Q39956136Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells
Q83389319Estrogen suppresses expression of the matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs (RECK) within the mouse uterus
Q37719954Expression of RECK and MMP-2 in salivary adenoid cystic carcinoma: Correlation with tumor progression and patient prognosis
Q82039791Expression of matrix metalloproteinase regulator, RECK, and its clinical significance in osteosarcoma
Q61818499GAS5 Regulates RECK Expression and Inhibits Invasion Potential of HCC Cells by Sponging miR-135b
Q34479560HER-2/neu represses the metastasis suppressor RECK via ERK and Sp transcription factors to promote cell invasion
Q34206316HPV16 oncoproteins induce MMPs/RECK-TIMP-2 imbalance in primary keratinocytes: possible implications in cervical carcinogenesis.
Q35463638High-Mobility Group Box 1 Promotes Hepatocellular Carcinoma Progression through miR-21-Mediated Matrix Metalloproteinase Activity
Q40196754Higher expression and activity of metalloproteinases in human cervical carcinoma cell lines is associated with HPV presence.
Q53618959Immunohistochemical detection of MT1-MMP, RECK, and EMMPRIN in ameloblastic tumors.
Q36215892Keratinization-associated miR-7 and miR-21 regulate tumor suppressor reversion-inducing cysteine-rich protein with kazal motifs (RECK) in oral cancer.
Q24540058Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma
Q42520559Localization of the membrane-anchored MMP-regulator RECK at the neuromuscular junctions
Q44201369Low expression of RECK indicates a shorter survival for patients with invasive breast cancer
Q73437447Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs: a prognostic marker for good clinical outcome in human breast carcinoma
Q34696685MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis
Q39240146MicroRNA-15a promotes neuroblastoma migration by targeting reversion-inducing cysteine-rich protein with Kazal motifs (RECK) and regulating matrix metalloproteinase-9 expression
Q78357688Molecular pathogenesis of human hepatocellular carcinoma
Q36142628RECK is not an independent prognostic marker for breast cancer
Q35810123Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature
Q36921698Recklessness as a hallmark of aggressive cancer
Q42257030Reversion-inducing cysteine-rich protein with Kazal motifs gene expression and its clinical significance in peripheral T-cell lymphoma
Q34770322TIMP-2 upregulates RECK expression via dephosphorylation of paxillin tyrosine residues 31 and 118.
Q28504785The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis
Q34668320The prognostic molecular markers in hepatocellular carcinoma
Q24337918The tumor suppressor RECK interferes with HER-2/Neu dimerization and attenuates its oncogenic signaling
Q78732223Transcriptional control of the RECK metastasis/angiogenesis suppressor gene
Q48552283Valproic acid affected the survival and invasiveness of human glioma cells through diverse mechanisms.

Search more.